PROCEPT BioRobotics Corporation announced that it has successfully completed the first commercial Aquablation therapy procedures in Japan. The procedures were carried out at two premier medical institutions, in association with the 100 patient post-market surveillance study. Completing the first commercial procedures in Japan represents another important milestone in PROCEPT BioRobotics?

global expansion, highlighting the growing acceptance and recognition of Aquablation therapy as a pioneering solution for BPH patients.